[1] Swigoňová Z, Mohsen AW, Vockley J. Acyl-CoA dehydrogenases: dynamic history of protein family evolution[J].J Mol Evol, 2009, 69:176-193.
[2] Dewulf JP, Barrea C, Vincent MF, et al. Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: report on nine patients[J]. Mol Genet Metab, 2016, 118(3):185-189.
[3] Hooper AJ, Adams LA, Burnett JR. Genetic determinants of hepaticsteatosis in man[J]. J Lipid Res,2011,52(4):593-617.
[4] Nouws J, Nijtmans L, Houten SM, et al. Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I[J]. Cell Metab,2010,12(3):283-294.
[5] Nouws J, Wibrand F, van den Brand M, et al. A patient with complex I deficiency caused by a Novel ACAD9 mutation not responding to riboflavin treatment[J]. JIMD Reports, 2013, 12:37-45.
[6] Haack TB, Danhauser K, Haberberger B, et al.Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency[J].Nature Genetics, 2010, 42(12):1131-1134.
[7] Aintablian HK, Narayanan V, Belnap N, et al. An atypical presentation of ACAD9 deficiency: diagnosis by whole exome sequencing broadens the phenotypic spectrum and alters treatment approach[J].Mol Genet Metab Rep,2017, 10(C):38-44.
[8] Fragaki K, Chaussenot A, Boutron A, et al. Assembly defects of multiple respiratory chain complexes in a child with cardiac hypertrophy associated with a novel ACAD9 mutation[J]. Mol Genet Metab,2017,121(3):224-226.
[9] Lagoutte-Renosi J, Ségalas-MilazzoI, Crahes M, et al. Lethal neonatal progression of fetal cardiomegaly associated to ACAD9 deficiency[J]. JIMD Reports, 2015, 28:1-10.
[10] Collet M,Assouline Z, Bonnet D, et al. High incidence and variable clinical outcome of cardiac hypertrophy due to ACAD9 mutations in childhood[J]. Eur J Hum Genet, 2016, 24(8):1112-1116.
[11] Repp BM, Mastantuono E, Alston CL, et al. Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective[J]. Orphanet J Rare Dis, 2018,13(1):120.
[12] Leipnitz G, Mohsen AW, Karunanidhi A, et al. Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulum-mitochondria crosstalk, and reactive oxygen species in fibroblasts from patients with complex I deficiency[J]. Sci Rep, 2018, 8(1):1165. |
